At SIYOM Consulting, we help healthcare and life sciences organizations turn AI ambition into measurable, responsible growth. Our services span strategy, evaluation, leadership, and communication — all grounded in scientific rigor and delivered with calm, candid insight. Whether we’re guiding an executive team through a critical AI decision, assessing the credibility of a startup’s model, or demystifying machine learning for frontline teams, our goal is the same: to help you move faster by learning faster.
Seasoned Consulting and Fractional Leadership
This category includes SIYOM’s high-touch consulting services and fractional executive leadership offerings — ideal for organizations seeking to move quickly and responsibly from AI ambition to execution. Whether serving as a trusted advisor or stepping in as a part-time Chief AI or Data Officer, we bring 30 years of hands-on experience to guide teams through complex decision-making, capability building, and change management. These engagements are founder-led, grounded in the scientific method, and designed to help leaders and operators make strategic, evidence-informed decisions that scale. Every roadmap, dashboard, and model we shape is aligned to business outcomes and stress-tested through inquiry — not assumption.
Strategic Data and AI Consulting Services
Transforming complex AI and data challenges into actionable, evidence-based strategies that accelerate performance, drive continuous learning, and deliver measurable outcomes at scale.
In these strategic engagements, SIYOM brings boardroom-level perspective and scientific discipline to your AI initiatives. Every consulting engagement is founder-led and tailored to your context, ensuring guidance that is both visionary and pragmatic. We clarify ambitions, set priorities, and design roadmaps that connect data, operations, and strategy. Our method replaces “certainty theater” with Constructive Inquiry: testing assumptions, measuring outcomes, and iterating quickly to drive progress that stands up to scrutiny. The result is an adaptive, evidence-backed strategy that transforms AI from a risky experiment into a reliable engine for growth and learning.
Fractional CAIO/CDO Services
Strategic leadership on demand — guiding healthcare and life-sciences organizations to harness data and AI with scientific rigor, ethical integrity, and measurable impact when and where it’s needed.
For organizations that need top-tier data and AI leadership without committing to a full-time executive, SIYOM offers fractional C-suite support. Our founder, Marc D. Paradis, serves as a part-time Chief AI Officer or Chief Data Officer — providing executive-level leadership to design and scale responsible AI and data strategies that create verifiable value[2]. He translates vision into execution, ensuring every model and dashboard serves a defined purpose and outcome[2]. As a fractional leader, he embeds within your team to drive progress and mentor internal talent, offering strategic continuity and expertise exactly when and where it’s most effective.
Scientific, Advisory and Board Participation
In this category, SIYOM provides direct support to boards, C-suites, and governance committees navigating the high-stakes complexity of AI transformation. We serve as a trusted third-party advisor — offering constructive challenge, translating technical uncertainty into strategic clarity, and guiding leadership teams to anticipate risk without stifling innovation. From sitting on advisory boards to designing oversight frameworks, our work is grounded in evidence, aligned to mission, and always shaped by the core belief that humility and transparency lead to better outcomes. This is not compliance theatre — it’s a model for how bold innovation and ethical leadership can coexist.
Development of Data and AI Governance Policies
Building governance frameworks that align AI innovation with integrity for healthcare and life sciences, turning compliance into competitive advantage.
Governance is confidence. SIYOM helps healthcare and life-sciences organizations craft policies that embed transparency, accountability, and safety into innovation. Grounded in deep awareness of regulations like HIPAA, FDA, GDPR, and CCPA and guided by scientific discipline, our frameworks make ethics and efficiency coexist. We design AI governance structures and compliance practices that not only meet regulatory requirements but also instill trust among stakeholders. By turning compliance obligations into opportunities for quality and trust, we ensure that bold innovation can thrive responsibly under clear oversight.
Board Participation/Leadership
Independent, evidence-driven oversight for healthcare AI and data strategy — bringing scientific rigor, ethical perspective, and strategic foresight into the boardroom’s technology decisions as organizations navigate digital transformation responsibly.
As an independent board advisor, Marc d. Paradis provides an unbiased expert perspective on Data and AI initiatives at the highest level of governance. He serves as an advisor or board member for organizations seeking principled AI governance and risk foresight. In these roles, he helps boards align technology decisions with the organization’s mission, ensuring transparency and accountability at every step. With a blend of scientific expertise and operational savvy, Marc brings credibility and constructive challenge to boardroom discussions. By posing the right questions and illuminating blind spots, he enables leadership to make informed, mission-aligned decisions about technology investments and risks.
Due Diligence, Testimony and Evaluation
SIYOM supports investors, legal teams, and healthcare leaders with rigorous analysis of data and AI solutions, vendors, or internal initiatives. We interrogate the structure, claims, and consequences of AI systems to reveal what is real, what is replicable, and what is merely marketing. Whether you’re evaluating a startup for acquisition, defending a decision in court, or reassessing an in-flight program, our assessments cut through the noise with discipline, transparency, and insight. We convert complexity into clarity — giving boards, buyers, and regulators the confidence to act decisively, knowing the technical and ethical terrain has been properly mapped.
Due Diligence of Data and AI Companies
Evaluating healthcare AI and data ventures with scientific precision to separate signal from hype – ensuring investors gain a clear view of reality versus rhetoric in AI innovation.
SIYOM provides rigorous due diligence support, serving as a trusted technical advisor to investors evaluating healthcare technology opportunities. We perform independent technical and governance assessments for health systems, lifesciences companies, start-ups, investment banks, venture capital and private equity firms. Our team interrogates algorithms, datasets, and product claims to reveal what’s genuinely replicable and what’s mere “theater” – delivering confidence grounded in evidence. Through this analysis, we spotlight both hidden risks and unrecognized value, enabling you to make investment decisions with eyes wide open. By translating complex findings into business impact, we help ensure your decisions are driven by facts rather than buzzwords.
Expert Witness Testimony
Translating complex data and AI issues into clear, courtroom-ready insights -providing objective, evidence-grounded expert testimony for high-stakes legal and regulatory decisions in healthcare and life sciences.
When disputes or investigations involve advanced data or AI systems in healthcare or life sciences, Marc Paradis serves as an expert witness who bridges the gap between technical complexity and legal clarity. Drawing on decades of hands-on experience, he translates algorithms, data analyses, and industry standards into plain-language explanations that judges and juries can trust. Marc’s testimony is always rooted in verifiable evidence and presented with scientific impartiality, helping decision-makers separate fact from speculation. Whether in court or before regulators, his calm, authoritative delivery ensures that truth stands above hype when AI and data are under scrutiny.
Education and Thought Leadership Engagements
SIYOM offers a range of speaking, writing, and facilitation engagements that help audiences understand and lead in an AI-powered world. From C-suite workshops to conference keynotes, from industry whitepapers to cross-disciplinary fireside chats, we translate complexity into clarity — and ambiguity into curiosity. These engagements are grounded in Constructive Inquiry: we don’t just inform, we provoke dialogue, challenge dogma, and foster a culture where being “righter, faster” is more important than being assertive. The result is more aligned teams, more thoughtful leadership, and more nuanced industry discourse — all critical ingredients for AI maturity and innovation with integrity.
Education and Communication Engagements
Demystifying AI through education and clear communication — helping cross-functional teams in healthcare build practical understanding and a culture of informed, curious, and responsible innovation through hands-on learning.
SIYOM turns buzzwords into understanding through tailored workshops, training sessions, and coaching for your teams. We demystify data science and AI for non-technical leaders, clinicians, and operational staff by using plain language and real-world examples. These education engagements translate high-level AI strategies into day-to-day practices, empowering people at all levels to make data-driven decisions confidently. By fostering open dialogue and embracing “dumb questions,” we create a safe learning environment that fuels disciplined curiosity. The result is a workforce that not only understands AI but is also motivated to use it responsibly to improve outcomes.
Data and AI Thought Leadership
Shaping the healthcare and life-sciences AI conversation with evidence, integrity, and clarity, translating complex ideas into actionable insights through impactful writing, speaking, and research to drive ethical innovation.
As a thought leader, Marc d. Paradis engages executives and clinicians alike with forward-thinking insights on AI. He leverages platforms ranging from industry conferences to academic journals to advance the practice of ethical AI and data strategy. Through his writing and speaking, Marc challenges hype with evidence and turns jargon into clear concepts, always tying technology back to real-world impact. His voice bridges science and society, ensuring discussions around AI remain honest and grounded. By encouraging open debate and rigorous inquiry as engines of progress, he shapes an industry narrative that is both aspirational and accountable.
Contact Us to Find Out More
Connect with us to unlock AI’s full potential.